Arcutis Biotherapeutics, Inc. short interest in 2026
In 2026, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 12.43% of shares outstanding on 15 Jan 2026 to 14.69% on 15 Sep 2026, a change of +2.26 percentage points. The year's high was 14.69% on 15 Sep 2026 and its low 10.09% on 31 Jul 2026, averaging 12.72% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.62 days on 30 Apr 2026. Full history: Arcutis Biotherapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 12.43% (15 Jan 2026)
- End of year
- 14.69% (15 Sep 2026)
- Change
- +2.26 pp
- High
- 14.69% (15 Sep 2026)
- Low
- 10.09% (31 Jul 2026)
- Average
- 12.72%
- Highest days to cover
- 16.62 (30 Apr 2026)
- SEC filings marked
- 5
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 12.43% | 8.41 | |
| 30 Jan 2026 | 13.07% | 13.88 | |
| 13 Feb 2026 | 13.37% | 14.06 | |
| 27 Feb 2026 | 12.48% | 9.73 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 12.86% | 12.56 | |
| 31 Mar 2026 | 13.72% | 11.11 | |
| 15 Apr 2026 | 13.54% | 15.62 | |
| 30 Apr 2026 | 13.49% | 16.62 | |
| 15 May 2026 | 14.03% | 7.30 | 10-Q filed |
| 29 May 2026 | 12.97% | 8.44 | |
| 15 Jun 2026 | 12.65% | 10.04 | |
| 30 Jun 2026 | 11.21% | 6.33 | |
| 15 Jul 2026 | 10.84% | 9.34 | |
| 31 Jul 2026 | 10.09% | 10.74 | |
| 14 Aug 2026 | 11.71% | 8.04 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 13.17% | 9.41 | |
| 15 Sep 2026 | 14.69% | 8.54 |
See also: Arcutis Biotherapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.